Table 1.
Baseline characteristics of FHBL patients and healthy controls
| Characteristic | FHBL (n = 7) | Control (n = 7) | p value |
|---|---|---|---|
| Age (years) | 47 (22–61) | 45 (22–60) | NS |
| BMI (kg/m2) | 27 (22–32) | 26 (20–36) | NS |
| WHR (cm) | 1.02 (0.97–1.05) | 1.01 (0.94–1.12) | NS |
| Total cholesterol (mmol/l) | 1.94 (1.39–2.81) | 4.75 (3.47–5.23) | <0.01 |
| Triacylglycerol (mmol/l) | 0.14 (0.05–0.49) | 0.76 (0.40–1.07) | <0.01 |
| ApoB (g/l) | 0.24 (0.12–0.4) | 0.83 (0.54–0.90) | <0.01 |
| HDL (mmol/l) | 1.19 (0.7–1.53) | 1.3 (0.79–1.83) | NS |
| HOMA index | 1.58 (0.21–2.35) | 0.76 (0.23–1.58) | NS |
| Aspartate aminotransferase (U/l) | 39 (22–49) | 28 (14–34) | <0.05 |
| Alanine aminotransferase (U/l) | 62 (22–106) | 23 (10–32) | 0.05 |
| C-reactive protein (mg/l) | 1.4 (0.50–3.10) | 1.0 (0.50–6.20) | NS |
Data are median (range)